I keep coming back to one uncomfortable observation. People are getting sick in unusual ways, and the pattern does not fit neatly into the old categories I was trained to use.
When I looked at the UK NHS Hospital Episode Statistics, I was not looking for one isolated diagnosis. I was looking across disease patterns. I was looking at trajectories. I was looking at whether conditions that had previously been stable had suddenly changed direction. When hundreds of diagnostic codes begin to show altered slopes, I cannot dismiss that as background noise. I can allow for coding changes. I can allow for shifts in clinical behavior. I can allow for post-pandemic disruption. But I cannot honestly say there is nothing there.
That is the problem with this whole discussion. Many people want COVID to be over, and I understand that emotionally. Everyone is tired of it — clinicians, researchers, the public. But biology does not stop because we are tired. If something has altered immune behavior across the population, then moving on too quickly is not wisdom. It is avoidance.
What I am trying to do is make sense of what I see clinically — why someone can appear to recover from one infection, then another, then deteriorate completely after a later episode. They may think the last infection caused everything. I suspect that is often not the full story.
Why the Single-Event Explanation Fails
The conventional model is too simple. A person gets COVID. They recover or they do not. If they develop Long COVID, we assume one infection must have triggered it. Sometimes that is true. But increasingly I think that model misses a more important pattern.
I am seeing people who had a first infection and bounced back quickly. They were tired for a few days or weeks, then returned to normal. They had a second infection, perhaps in 2022 or 2023, and recovered again, but not quite as cleanly. They started to notice small things. More fatigue, more gut disturbance, the odd palpitation, new sensitivity to foods. Strange inflammatory symptoms that did not seem to belong together.
Then a third or fourth exposure occurs, and the person tips. They can no longer function. The full picture appears: dysautonomia, gut symptoms, headaches, sleep disruption, post-exertional crashes, brain fog, palpitations, inflammatory pain. And the final infection may have seemed mild. It may not even have been recognized as COVID. So patient and doctor both miss the connection.
That is where I think the mistake lies. The issue may not be the apparent severity of the last infection. It may be the cumulative immune burden that preceded it.
The Spike Splinter Concept
When I think about the spike protein, I do not think only about the whole structure. I think about what happens when the immune system tries to break it down.
In some people, I suspect the spike protein is not degraded cleanly. Instead of being dismantled and cleared, fragments remain. I describe these as splinters or shards — not because it is a technical term, but because it helps explain the clinical pattern. These fragments may irritate the very immune cells that are supposed to clear them.
The macrophage is central here. A macrophage is one of the body’s clean-up and defense cells, engulfing debris, pathogens, damaged material, and immune complexes. But if it takes in something it cannot properly process, it does not simply shrug and move on. It can become activated. It can stay activated. It can continue releasing inflammatory signals.
That is the storm I am concerned about. Not always the dramatic cytokine storm of severe acute COVID, but a quieter, chronic, smoldering one — a macrophage-driven inflammatory state that does not resolve.
This is why I do not see Long COVID as purely a vaccine-injury issue, though I do think some people develop a Long COVID-like illness after vaccination. Nor do I see it as purely an infection issue. I see it as a spike-exposure and immune-handling issue. The source may differ. The immune consequence may converge.
The Threshold Problem
The key concept is the threshold.
Every person appears to have a different immune tolerance. I think of it like alcohol tolerance. One person becomes tipsy after two glasses of wine. Another can drink six before showing obvious effects. The exposure matters, but the threshold matters just as much.
The same principle may apply to spike-related immune activation. Some people have a high threshold. They may have repeated exposures and still appear well. Others have a lower threshold. They may develop Long COVID after a single infection in 2020, before vaccines were even available, because their immune system reached the tipping point early.
This is why simplistic arguments fail. It is not enough to ask, “How many infections did you have?” I need to ask: What was your baseline immune state? How strong was your mucosal immunity? Were there gut problems already? Was there pre-existing inflammation? Were there mast cell issues, autoimmunity, metabolic dysfunction, poor sleep, chronic stress, or repeated immune triggers?
The same exposure does not produce the same outcome in every person, because the immune terrain is not the same.
Why Mild Infection Can Still Matter
This is the part many people do not grasp. Exposure is not the same as infection severity.
If someone has strong mucosal immunity, the virus may remain largely in the upper airway. The immune system deals with it locally, systemic exposure is limited, and the body clears the problem before it becomes a deeper immune event.
But if mucosal immunity is weak, the same apparently mild infection may break through more easily. It may expose the systemic immune system to more viral material. It may activate monocytes and macrophages. It may add another layer of inflammatory burden.
So a person can say, “It was only a mild infection,” and still be wrong about its biological impact. Mild symptoms do not necessarily mean mild immune consequence. That is a dangerous assumption.
This is why repeated infection matters. Not because every infection causes obvious damage, but because each exposure may move a susceptible person closer to their threshold. They may feel fine until they are not. That is how many chronic inflammatory states behave. The body compensates for a long time, then suddenly the compensation fails.
What This Means Clinically
Clinically, I think this changes the whole conversation.
Instead of asking only, “How do I treat the symptoms?” I am asking, “How do I reduce the inflammatory load and raise the threshold?”
That points to two broad strategies. The first is to reduce exposure: lower the chance of repeated infection and improve mucosal defense. The second is to improve tolerance: strengthen the body’s capacity to handle immune triggers without tipping into chronic inflammation.
For many people, this will not be solved by one supplement or one medication. That is fantasy thinking. If the gut is driving immune activation, then the gut has to be addressed. If food is repeatedly triggering inflammation, then diet has to change. If poor sleep, stress, metabolic dysfunction, and dysbiosis are lowering the immune threshold, then those factors cannot be ignored.
This is where people often resist the truth. They want recovery without changing the conditions that helped create the problem. But if the immune system is already close to its threshold, continuing the same lifestyle while hoping for a different biological outcome is not a serious strategy.
Join Masterclass Live Here >
Interested in the FREE Taster session - Email info@vejonhealth.com (Limited Availability)
The Future of Long COVID Education
I think this threshold model will become increasingly important in how clinicians understand Long COVID.
At present, patients often present with symptoms that seem disconnected: gut disturbance, palpitations, headaches, dizziness, fatigue, food intolerance, brain fog, sleep disruption. The standard medical system struggles because it is trained to look for a single-organ diagnosis. But Long COVID often behaves like a system-level immune disorder.
The macrophage model helps make sense of that. If macrophages are persistently activated, and if that activation interacts with the gut, blood vessels, nervous system, and lymphatics, then the scattered symptoms are not random. They are different expressions of the same unresolved immune state.
That does not mean every patient is the same. It means the clinical task is to identify where each patient sits on the threshold curve. Are they early, still compensating? Are they approaching the tipping point? Have they already tipped into chronic inflammation? Are they relapsing repeatedly because the threshold remains low?
Those are the questions I think clinicians will eventually have to ask.
The Real Warning
The warning is not that everyone will develop Long COVID. That is not what I am saying.
The warning is that many people may be accumulating immune stress without realizing it. They may believe they are fine because they recovered from the last infection. But recovery from symptoms is not necessarily the same as full immune resolution.
If spike fragments persist in immune cells, if macrophages remain activated, if mucosal immunity remains weak, and if the gut continues to drive inflammation, then the person may be closer to the edge than they think.
That is why I continue to talk about this even when many people have lost interest. I am not chasing the public mood. I am interested in the pattern. And the pattern tells me we are still in the early stages of understanding what repeated COVID exposure is doing to population health.
Where I Think We Go Next
I think the future lies in resilience. Not vague wellness language, but genuine immune resilience.
I want to understand how to reduce systemic exposure, improve mucosal defense, restore gut stability, calm macrophage activation, and raise the threshold before people tip into chronic disease. That is the direction this work has to go.
This is not a sprint. It is a marathon. The people who recover best will likely be those who stop looking for a single magic answer and start understanding the terrain. They will ask better questions. What is driving my inflammation? What lowers my threshold? What increases my resilience? What exposures do I need to reduce? What do I need to change permanently?
That is the serious conversation.
COVID may feel over socially, but clinically and immunologically I do not believe we are finished with it. The spike splinter problem, the macrophage activation problem, and the threshold problem may explain why so many people are still struggling.
And if that is correct, then the most important question is not simply, “How do I treat Long COVID?”
The more important question is, “How do I stop the next exposure from pushing more people over the edge?”
